SEC Form 4 · accession 0001472595-17-000002
R1 RCM INC. · RCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John B Henneman III
Director
Period of report
Jan 3, 2017
Accepted (ET)
Jan 4, 2017 · 4:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001472595
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F1 | $2.29 | Jan 3, 2017 | A | 14,098 | A | Jan 3, 2017 | Jan 3, 2027 | Common Stock | 14,098 | 14,098 | D |
Explanation of responses
- F1This option was issued to the reporting person pursuant to the Accretive Health director compensation plan in lieu of retainer fees of $15,000.